Optical Coherence Tomography Angiography and Pseudophakic Cystoid Edema
Peripapillary Vascular Density in the Pathogenesis of Pseudophakic Cystoid Edema
1 other identifier
observational
25
0 countries
N/A
Brief Summary
This study evaluates the retinal vascular features in macula and papillary regions in patients affected by pseudophakic cystoid edema using optical coherence tomography angiography
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2016
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedFirst Submitted
Initial submission to the registry
September 27, 2021
CompletedFirst Posted
Study publicly available on registry
November 11, 2021
CompletedNovember 11, 2021
November 1, 2021
5 years
September 27, 2021
November 2, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
OCTA and pseudophakic cystoid macular oedema
The parameters analyzed by OCTA three months after surgery are: Vessel density (%) of superficial capillary plexus, deep capillary plexus, coriocapillary plexus in macular region Vessel density (%) of radial peripapillary capillary plexus in papilllary region
3 months
Study Arms (2)
Patients group
Subjects over 18 years that after cataract surgery, showed pseudophakic cystoid macula edema.
Control Group
Normal subjects over 18 years that did not show pseudophakic cystoid macula edema.
Interventions
Patients underwent OCT angiografia after cataract surgery
Eligibility Criteria
The participans were older than 18 years with diagnosis of pseudophakic cystoid macular oedema. The participans did not present other ophthalmological diseases.
You may qualify if:
- age older than 60 years
- diagnosis of pseudophakic cystoid macular oedema
- treatment-naïve for pseudophakic cystoid macular oedema
- absence of other ocular diseases, responsible for macular edema (retinal vein occlusion, diabetic retinopathy, age-related macular degeneration)
You may not qualify if:
- age younger than 60 years
- No diagnosis of pseudophakic cystoid macular oedema
- previous treatment for pseudophakic cystoid macular oedema
- presence of other ocular diseases, responsible for macular edema (retinal vein occlusion, diabetic retinopathy, age-related macular degeneration)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Gilda Cennamo
Università Federico II
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 27, 2021
First Posted
November 11, 2021
Study Start
January 1, 2016
Primary Completion
December 15, 2020
Study Completion
December 30, 2020
Last Updated
November 11, 2021
Record last verified: 2021-11